Legal status · United Kingdom
Is Efimosfermin alfa legal in the United Kingdom?
No. Efimosfermin alfa is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Efimosfermin alfa in the United Kingdom at a glance
| Classification | Investigational, not licensed |
|---|---|
| MHRA approval status | Not approved by MHRA; investigational |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Efimosfermin alfa profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.
What this means
- 01
Efimosfermin alfa is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Efimosfermin alfa is
GSK's once-monthly FGF21 analog, acquired for $1.2 billion upfront, with FDA Breakthrough Therapy designation for MASH and Phase 2 results published in 2026.
Efimosfermin is an engineered FGF21 variant with a half-life long enough for monthly injection, the only monthly FGF21 in development. Its Phase 2 in F2/F3 MASH showed histologic benefit and good tolerability over 24 weeks, earning Breakthrough Therapy status from the FDA and PRIME from the EMA.
Mechanism: Long-acting FGF21 receptor agonism that reduces liver fat, inflammation and fibrosis.
Regulatory history: Investigational; Breakthrough Therapy designation
How MHRA treats this kind of product
Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.
The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Efimosfermin alfa at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Efimosfermin alfa in other countries
Frequently asked questions
Is Efimosfermin alfa legal in the United Kingdom?
No. Efimosfermin alfa is not approved for any medical use in the United Kingdom; its classification is "Investigational, not licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Efimosfermin alfa in the United Kingdom?
No approved product exists to buy. In the United Kingdom Efimosfermin alfa is classified as "Investigational, not licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Efimosfermin alfa MHRA approved?
No. In the United Kingdom Efimosfermin alfa is classified as "Investigational, not licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: Investigational; Breakthrough Therapy designation. Evidence level: Moderate.
Related compounds in the United Kingdom
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Efimosfermin alfa live on its compound profile.
Efimosfermin alfa profileThis page is general information about the regulatory status of Efimosfermin alfa in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.